This study was funded by the National Key Research and Development Program of China (2021YFC2009304) and Project of Science and Technology Department of Sichuan Province (Grant ID:
2021YFS0117).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区医学
小类|3 区外科
最新[2023]版：
大类|3 区医学
小类|3 区外科
第一作者：
第一作者机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China
通讯作者：
通讯机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China[*1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
推荐引用方式(GB/T 7714)：
Liu Xiaoyang,Yang Luchen,Dong Qiang.The identification of cancer-associated fibroblasts signature for prognosis and drug response in renal papillary cell carcinoma[J].Asian journal of surgery.2023,doi:10.1016/j.asjsur.2023.05.073.
APA：
Liu Xiaoyang,Yang Luchen&Dong Qiang.(2023).The identification of cancer-associated fibroblasts signature for prognosis and drug response in renal papillary cell carcinoma.Asian journal of surgery,,
MLA：
Liu Xiaoyang,et al."The identification of cancer-associated fibroblasts signature for prognosis and drug response in renal papillary cell carcinoma".Asian journal of surgery .(2023)
